Grapefruit isn't the only fruit that interferes with medication

Most people know the grapefruit warning. Far fewer know it isn’t really about grapefruit — it’s about a family of compounds that several other fruits also carry, and about a second, completely separate mechanism that makes one fruit dangerous for a specific group of people regardless of what they’re taking.

Here’s what the evidence actually supports, and — just as usefully — what it doesn’t.

This is general information, not medical advice. If any of it applies to you, the conversation to have is with your pharmacist or doctor, who can check your specific medicines. Don’t stop or change a prescription based on a fruit article.

Mechanism one: the enzyme blockers

Your small intestine lines its walls with an enzyme called CYP3A4, which breaks down a large share of oral medicines before they ever reach your bloodstream. Drug doses are calibrated assuming that happens.

Grapefruit contains furanocoumarins — chiefly bergamottin and 6′,7′-dihydroxybergamottin — which inactivate that enzyme. Less of the drug gets broken down, so more of it reaches your blood than the dose intended. The effect can last a day or more and is not avoided by spacing the juice away from the pill.

The important part is that furanocoumarins are not unique to grapefruit.

Pomelo is grapefruit’s parent species — grapefruit is a pomelo × sweet orange hybrid — and carries the same class of compounds. If you have been told to avoid grapefruit, pomelo belongs in the same conversation.

Seville orange, the bitter marmalade orange, is the one that surprises people. Its peel and pulp carry furanocoumarin levels comparable to or higher than grapefruit’s, including bergapten. In a controlled study, Seville orange juice raised blood levels of the blood-pressure drug felodipine by 76%, against 93% for grapefruit juice — the same order of effect (Malhotra et al., Clin Pharmacol Ther). Ordinary sweet oranges do not do this.

Pomegranate is a maybe. Some laboratory work suggests it inhibits the same enzymes, and there are scattered case reports involving blood thinners and statins, but the human evidence is much thinner and less consistent than grapefruit’s. Worth mentioning to a pharmacist; not worth panicking about.

Mechanism two: the kidney problem

Starfruit belongs on this list for an entirely different reason, and it is the most serious item here.

Starfruit contains caramboxin, a neurotoxin that healthy kidneys clear without difficulty. Kidneys that don’t work properly cannot. In people with chronic kidney disease or on dialysis, even small amounts have caused intractable hiccups, confusion, seizures and deaths — this is documented in the nephrology literature, not theoretical (Indian Journal of Nephrology; Brazilian Journal of Nephrology).

This isn’t a drug interaction; it’s a filtration problem. Which means it applies whether or not you take any medication at all. Guidance for people with kidney disease is to avoid starfruit entirely.

Its close cousin bilimbi carries a related but distinct risk: it is extremely high in oxalate, and concentrated raw bilimbi juice has caused acute oxalate kidney injury in otherwise healthy people. A hospital case series from Kerala described patients needing dialysis after drinking large quantities (Case Reports in Nephrology). Used as a souring agent in cooking, in recipe-sized amounts, it is a different exposure entirely.

The one that doesn’t hold up

Cranberry and warfarin is probably the fruit–drug warning most people have heard, and it has the weakest evidence on this page.

It began with case reports. But when researchers ran randomised controlled trials and looked at surrogate markers, they did not find the interaction. One systematic evaluation found a cranberry juice that inhibited warfarin metabolism in the test tube had no measurable effect on warfarin clearance in actual people (Journal of Experimental Pharmacology). A review of the case reports themselves classified only a small minority as well documented (The American Journal of Medicine).

The honest position is that the evidence is conflicting and low quality, and rigorous trials have not supported a clinically meaningful interaction. That does not mean “ignore your anticoagulation clinic” — warfarin is a narrow-margin drug and your clinic’s advice wins over any article. It does mean this particular warning has travelled much further than its evidence.

The short version

Fruit	Concern	How solid
Grapefruit	CYP3A4 inhibition	Well established
Pomelo	Same compounds, parent species	Well established
Seville orange	Same compounds, high levels	Well established
Starfruit	Caramboxin, kidney disease only	Well established, serious
Bilimbi	Oxalate load in raw juice	Documented case series
Pomegranate	Possible enzyme inhibition	Limited, inconsistent
Cranberry + warfarin	Claimed anticoagulant effect	Weak; trials don’t support it

If you take regular medication, the single most useful thing you can do is ask your pharmacist which of your specific medicines are CYP3A4 substrates. It takes a minute, and it replaces a list like this with an answer about you.

Related reading: pomelo vs grapefruit, and our full profile of starfruit, which carries the warning in more detail.